These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34644209)
41. Endothelial-specific Lee MJ; Jang Y; Han J; Kim SJ; Ju X; Lee YL; Cui J; Zhu J; Ryu MJ; Choi SY; Chung W; Heo C; Yi HS; Kim HJ; Huh YH; Chung SK; Shong M; Kweon GR; Heo JY J Cereb Blood Flow Metab; 2020 Jul; 40(7):1546-1561. PubMed ID: 31987007 [TBL] [Abstract][Full Text] [Related]
42. Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood-Brain Barrier. Ito S; Yanai M; Yamaguchi S; Couraud PO; Ohtsuki S J Pharm Sci; 2017 Sep; 106(9):2599-2605. PubMed ID: 28456720 [TBL] [Abstract][Full Text] [Related]
43. The Protective Effects of Acetazolamide Against Homocysteine-Induced Blood-Brain-Barrier Disruption by Regulating the Activation of the Wnt/β-Catenin Signaling Pathway. Li C; Zhang B Neurotox Res; 2022 Oct; 40(5):1261-1271. PubMed ID: 35920995 [TBL] [Abstract][Full Text] [Related]
44. Exposure to vehicle emissions results in altered blood brain barrier permeability and expression of matrix metalloproteinases and tight junction proteins in mice. Oppenheim HA; Lucero J; Guyot AC; Herbert LM; McDonald JD; Mabondzo A; Lund AK Part Fibre Toxicol; 2013 Dec; 10():62. PubMed ID: 24344990 [TBL] [Abstract][Full Text] [Related]
45. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Lossinsky AS; Shivers RR Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715 [TBL] [Abstract][Full Text] [Related]
46. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4. Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976 [TBL] [Abstract][Full Text] [Related]
47. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling. Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485 [TBL] [Abstract][Full Text] [Related]
48. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Gurnik S; Devraj K; Macas J; Yamaji M; Starke J; Scholz A; Sommer K; Di Tacchio M; Vutukuri R; Beck H; Mittelbronn M; Foerch C; Pfeilschifter W; Liebner S; Peters KG; Plate KH; Reiss Y Acta Neuropathol; 2016 May; 131(5):753-73. PubMed ID: 26932603 [TBL] [Abstract][Full Text] [Related]
49. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. Nikolakopoulou AM; Wang Y; Ma Q; Sagare AP; Montagne A; Huuskonen MT; Rege SV; Kisler K; Dai Z; Körbelin J; Herz J; Zhao Z; Zlokovic BV J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33533918 [TBL] [Abstract][Full Text] [Related]
50. Hypercapnia exacerbates the disruption of the blood‑brain barrier by inducing interleukin‑1β overproduction in the blood of hypoxemic adult rats. Ding H; Liu X; Li X; Wen M; Li Y; Han Y; Huang L; Liu M; Zeng H Int J Mol Med; 2020 Aug; 46(2):762-772. PubMed ID: 32626911 [TBL] [Abstract][Full Text] [Related]
51. Morphofunctional aspects of the blood-brain barrier. Nico B; Ribatti D Curr Drug Metab; 2012 Jan; 13(1):50-60. PubMed ID: 22292807 [TBL] [Abstract][Full Text] [Related]
55. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug. Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847 [TBL] [Abstract][Full Text] [Related]
56. Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery. Oikari LE; Pandit R; Stewart R; Cuní-López C; Quek H; Sutharsan R; Rantanen LM; Oksanen M; Lehtonen S; de Boer CM; Polo JM; Götz J; Koistinaho J; White AR Stem Cell Reports; 2020 May; 14(5):924-939. PubMed ID: 32275861 [TBL] [Abstract][Full Text] [Related]
57. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy. Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212 [TBL] [Abstract][Full Text] [Related]
58. Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1. Yanagida K; Liu CH; Faraco G; Galvani S; Smith HK; Burg N; Anrather J; Sanchez T; Iadecola C; Hla T Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4531-4536. PubMed ID: 28396408 [TBL] [Abstract][Full Text] [Related]
59. The RING finger- and PDZ domain-containing protein PDZRN3 controls localization of the Mg Marunaka K; Furukawa C; Fujii N; Kimura T; Furuta T; Matsunaga T; Endo S; Hasegawa H; Anzai N; Yamazaki Y; Yamaguchi M; Ikari A J Biol Chem; 2017 Aug; 292(31):13034-13044. PubMed ID: 28623232 [TBL] [Abstract][Full Text] [Related]
60. Identification of neuronal and angiogenic growth factors in an in vitro blood-brain barrier model system: Relevance in barrier integrity and tight junction formation and complexity. Freese C; Hanada S; Fallier-Becker P; Kirkpatrick CJ; Unger RE Microvasc Res; 2017 May; 111():1-11. PubMed ID: 27988246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]